Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX with Bevacizumab in Metastatic Gastroesophageal Cancer
NCT00673673Phase 2Completed
- Sponsor
- Yale University
- Start
- May 2008
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in gastroesophageal adenocarcinoma, gastric adenocarcinoma, sponsored by Yale University. Started May 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
gastroesophageal adenocarcinomagastric adenocarcinoma
Beyond the preview
Go deeper on NCT00673673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673673.